INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,302,547 | -15.3% | 5,919,146 | -2.8% | 0.00% | – |
| Q2 2023 | $2,717,678 | -85.7% | 6,086,623 | -73.8% | 0.00% | -100.0% |
| Q1 2023 | $19,041,101 | -47.6% | 23,220,858 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $36,323,225 | -2.3% | 23,284,119 | +8.1% | 0.00% | 0.0% |
| Q3 2022 | $37,162,000 | +7.8% | 21,544,710 | +8.1% | 0.00% | 0.0% |
| Q2 2022 | $34,471,000 | -46.8% | 19,925,606 | +10.4% | 0.00% | -50.0% |
| Q1 2022 | $64,788,000 | -28.8% | 18,046,901 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $91,043,000 | -30.8% | 18,244,914 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $131,528,000 | -21.9% | 18,369,653 | +1.1% | 0.00% | -20.0% |
| Q2 2021 | $168,452,000 | +3.6% | 18,171,701 | +3.7% | 0.01% | 0.0% |
| Q1 2021 | $162,541,000 | +28.9% | 17,515,053 | +23.0% | 0.01% | +25.0% |
| Q4 2020 | $126,050,000 | -20.8% | 14,242,941 | +3.9% | 0.00% | -33.3% |
| Q3 2020 | $159,060,000 | -57.2% | 13,712,189 | -0.5% | 0.01% | -60.0% |
| Q2 2020 | $371,471,000 | +478.7% | 13,783,674 | +59.8% | 0.02% | +400.0% |
| Q1 2020 | $64,186,000 | +154.8% | 8,627,087 | +13.0% | 0.00% | +200.0% |
| Q4 2019 | $25,195,000 | +57.3% | 7,634,600 | -2.3% | 0.00% | 0.0% |
| Q3 2019 | $16,021,000 | -29.3% | 7,814,385 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $22,665,000 | -17.6% | 7,708,829 | +4.5% | 0.00% | 0.0% |
| Q1 2019 | $27,504,000 | -5.2% | 7,373,473 | +1.7% | 0.00% | 0.0% |
| Q4 2018 | $29,008,000 | -25.0% | 7,251,925 | +4.2% | 0.00% | -50.0% |
| Q3 2018 | $38,696,000 | +44.2% | 6,959,341 | +1.7% | 0.00% | +100.0% |
| Q2 2018 | $26,834,000 | -12.2% | 6,845,338 | +5.5% | 0.00% | 0.0% |
| Q1 2018 | $30,565,000 | +11.7% | 6,489,233 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $27,371,000 | -35.4% | 6,627,505 | -0.9% | 0.00% | -50.0% |
| Q3 2017 | $42,395,000 | -1.1% | 6,687,058 | +22.3% | 0.00% | 0.0% |
| Q2 2017 | $42,878,000 | +21.8% | 5,469,310 | +2.9% | 0.00% | 0.0% |
| Q1 2017 | $35,193,000 | +76406.5% | 5,316,002 | +80592.2% | 0.00% | – |
| Q4 2016 | $46,000 | -35.2% | 6,588 | -12.3% | 0.00% | – |
| Q3 2016 | $71,000 | +14.5% | 7,516 | +11.6% | 0.00% | – |
| Q2 2016 | $62,000 | +47.6% | 6,737 | +39.6% | 0.00% | – |
| Q1 2016 | $42,000 | +2.4% | 4,825 | -19.9% | 0.00% | – |
| Q4 2015 | $41,000 | +412.5% | 6,021 | +363.9% | 0.00% | – |
| Q3 2015 | $8,000 | -27.3% | 1,298 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | -8.3% | 1,298 | -10.0% | 0.00% | – |
| Q1 2015 | $12,000 | -7.7% | 1,443 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | -7.1% | 1,443 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | -12.5% | 1,443 | 0.0% | 0.00% | – |
| Q2 2014 | $16,000 | – | 1,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |